Exchange: NASDAQ·Updated 07:30 PM EDT

COAG Hemab Therapeutics Holdings Inc.

$44.84
$4.65
(9.40%)
Today
Closed $44.84
$0.00
(0.00%)
After Hours
Reported EarningsAug 11
Mkt Cap$2.09B
Vol260,078.00

About COAG

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded in 2020 and is headquartered in Cambridge, MA.
35

Bearish Sentiment

How do you feel about COAG?

Advertisement|Remove ads.